EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data

Luísa Esteves, Francisco Caramelo, Domingos Roda, Isabel Marques Carreira iD, Joana Barbosa Melo iD, Ilda Patrícia Ribeiro iD

BioMed Research International · 04.04.2024 · 2024 · 1-8

DOI: 10.1155/2024/5582424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, erschienen am 04.04.2024. Verfasst von Luísa Esteves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is the most prevalent type of brain tumour; although advancements in treatment have been made, the median survival time for GBM patients has persisted at 15 months. This study is aimed at investigating the genetic alterations and clinical features of GBM patients to find predictors of survival. GBM patients’ methylation and gene expression data along with clinical information from TCGA were retrieved. The most overrepresented pathways were identified independently for each omics dataset. From the genes found in at least 30% of these pathways, one gene that was identified in both sets was further examined using the Kaplan-Meier method for survival analysis. Additionally, three groups of patients who started radio and chemotherapy at different times were identified, and the influence of these variations in treatment modality on patient survival was evaluated. Four pathways that seemed to negatively impact survival and two with the opposite effect were identified. The methylation status of PRKCB was highlighted as a potential novel biomarker for patient survival. The study also found that treatment with chemotherapy prior to radiotherapy can have a significant impact on patient survival, which could lead to improvements in clinical management and therapeutic approaches for GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansSurvival AnalysisMutationBiomarkers, TumorPrognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR) and Center of Investigation on Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, Coimbra, Portugal.
  • University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB) and Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.
  • Laboratory of Biostatistics and Medical Informatics, iCBR-Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Algarve Radiation Oncology Unit-Joaquim Chaves Saúde (JCS), Faro, Portugal.

ORCID-Profile: Isabel Marques Carreira, Joana Barbosa Melo, Ilda Patrícia Ribeiro

Zitieren

APA

Esteves, L., Caramelo, F., Roda, D., Carreira, I. M., Melo, J. B., & Ribeiro, I. P. (2024). Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data. BioMed Research International, 2024, 1-8. https://doi.org/10.1155/2024/5582424

Vancouver

Esteves L, Caramelo F, Roda D, Carreira IM, Melo JB, Ribeiro IP. Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data. BioMed Research International. 2024;2024:1-8. doi:10.1155/2024/5582424

BibTeX
@article{Esteves2024,
  author = {Esteves, Luísa and Caramelo, Francisco and Roda, Domingos and Carreira, Isabel Marques and Melo, Joana Barbosa and Ribeiro, Ilda Patrícia},
  title = {Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data},
  journal = {BioMed Research International},
  year = {2024},
  volume = {2024},
  pages = {1--8},
  doi = {10.1155/2024/5582424}
}
Kostenlos starten →